Laekna, Inc. (HKG:2105)
Hong Kong · Delayed Price · Currency is HKD 8.27
+1.86 (28.94%)
Sep 30, 2026, 4:08 PM HKT
Laekna Market Cap
Laekna has a market cap or net worth of 3.5 billion as of October 1, 2026. Its market cap has decreased by -49.41% in one year.
Market Cap
3.50B
Enterprise Value
2.38B
Revenue
296.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.27
ChartMarket Cap Chart
Since June 29, 2023, Laekna's market cap has decreased from 5.85B to 3.50B, a decrease of -40.19%. That is a compound annual growth rate of -14.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 3.50B | -38.34% |
| Dec 31, 2025 | 5.68B | 62.12% |
| Dec 31, 2024 | 3.50B | -54.90% |
| Dec 29, 2023 | 7.76B | 32.67% |
| Jun 29, 2023 | 5.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viva Biotech Holdings | 2.96B |
| Medtide | 2.94B |
| BioDlink International Company | 2.86B |
| Jiangsu Recbio Technology | 2.71B |
| Beijing Luzhu Biotechnology | 2.69B |
| HJ Science | 2.66B |
| Clover Biopharmaceuticals | 2.44B |
| Frontage Holdings | 2.40B |